Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
---|---|---|---|---|
Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
Börsenplätze | Performance | Management | Volatilität | Watchlist |
Historisch | Benchmark | Sharpe Ratio | ||
Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
120.63 EUR | -6.92 EUR | -5.43 % |
---|
Vortag | 127.55 EUR | Datum | 15.11.2024 |
Anzeige
Name | ISIN | Performance | |
---|---|---|---|
21Shares Ripple XRP ETP | CH0454664043 | 367.15% | |
21Shares Stacks Staking ETP | CH1258969042 | 227.84% | |
21Shares Stellar ETP | CH1109575535 | 216.44% | |
21Shares Cardano ETP | CH1102728750 | 207.61% | |
21Shares Sui Staking ETP | CH1360612159 | 144.26% | |
21Shares Aave ETP | CH1135202120 | 134.46% | |
21Shares Injective Staking ETP | CH1360612134 | 10.65% | |
21Shares Immutable ETP | CH1360612142 | -11.92% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Ripple XRP ETP | CH0454664043 | 475.30% | |
21Shares Aave ETP | CH1135202120 | 332.51% | |
21Shares Stellar ETP | CH1109575535 | 244.32% | |
21Shares Cardano ETP | CH1102728750 | 209.77% | |
21Shares Stacks Staking ETP | CH1258969042 | 145.10% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Ripple XRP ETP | CH0454664043 | 323.11% | |
21Shares Aave ETP | CH1135202120 | 232.41% | |
21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 181.47% | |
21Shares Stellar ETP | CH1109575535 | 144.11% | |
21Shares Crypto Mid-Cap Index ETP | CH1130675676 | 131.62% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Solana staking ETP | CH1114873776 | 1’596.10% | |
21Shares Ripple XRP ETP | CH0454664043 | 585.99% | |
21Shares Aave ETP | CH1135202120 | 494.88% | |
21Shares Bitcoin Core ETP | CH1199067674 | 476.42% | |
21Shares Bitcoin ETP | CH0454664001 | 461.88% |
Fundamentaldaten
Valor | 35004487 |
ISIN | LU1540961916 |
Emittent | HBM Partners |
Aufgelegt in | Luxembourg |
Auflagedatum | 28.04.2017 |
Kategorie | Branchen: Andere Sektoren |
Währung | EUR |
Volumen | 17’853’682.26 |
Depotbank | Pictet & Cie (Europe) S.A. (Luxembourg) |
Geschäftsjahresende | 31.12. |
Berichtsstand | 06.01.2025 |
Anlagepolitik
So investiert der HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund A Cap EUR Fonds: The investment objective of the Sub-Fund is to achieve long-term capital growth. The goal is to generate a value trend that exceeds the performance of the NASDAQ Biotechnology Index (the “Benchmark”). No guarantee can be given that the investment objective will be achieved.
ETP Performance: HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund A Cap EUR Fonds
Performance 1 Jahr | 22.08 | |
Performance 2 Jahre | 10.74 | |
Performance 3 Jahre | -8.47 | |
Performance 5 Jahre | 14.32 | |
Performance 10 Jahre | - |